PPAR‐γ‐induced changes in visceral fat and adiponectin levels are associated with improvement of steatohepatitis in patients with NASH

BACKGROUND AND AIMS: Peroxisome proliferator‐activated receptor (PPAR)‐γ agonists decrease hepatic/visceral fat (VF) and improve necroinflammation despite subcutaneous (SC) fat weight‐gain. Understanding the impact of changes in VF, VF‐to‐SC fat distribution (VF/SC) and adiponectin (ADPN) levels in...

Descripción completa

Detalles Bibliográficos
Autores principales: Gastaldelli, Amalia, Sabatini, Silvia, Carli, Fabrizia, Gaggini, Melania, Bril, Fernando, Belfort‐DeAguiar, Renata, Positano, Vincenzo, Barb, Diana, Kadiyala, Sushma, Harrison, Stephen, Cusi, Kenneth
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Metabolic & Toxic Liver Diseases
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9290929/
https://www.ncbi.nlm.nih.gov/pubmed/34219361
http://dx.doi.org/10.1111/liv.15005

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9290929/
https://www.ncbi.nlm.nih.gov/pubmed/34219361
http://dx.doi.org/10.1111/liv.15005

Ejemplares similares